Co-Authors
This is a "connection" page, showing publications co-authored by Roberto Cauda and Maurizio Sanguinetti.
Connection Strength
0.486
-
Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother. 2008 Nov; 62(5):1130-7.
Score: 0.097
-
Sarilumab use in severe SARS-CoV-2 pneumonia. EClinicalMedicine. 2020 Oct; 27:100553.
Score: 0.057
-
The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach. Eur Rev Med Pharmacol Sci. 2019 Apr; 23(7):2978-2985.
Score: 0.051
-
Performance evaluation of the (1,3)-ß-D-glucan detection assay in non-intensive care unit adult patients. Infect Drug Resist. 2019; 12:19-24.
Score: 0.050
-
Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes. Clin Microbiol Infect. 2019 Apr; 25(4):474-480.
Score: 0.048
-
Systematic clinical management of patients with candidemia improves survival. J Infect. 2018 08; 77(2):145-150.
Score: 0.048
-
A 72-h intervention for improvement of the rate of optimal antibiotic therapy in patients with bloodstream infections. Eur J Clin Microbiol Infect Dis. 2018 Jan; 37(1):167-173.
Score: 0.046
-
Antibodies against a ß-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients. Sci Rep. 2017 06 02; 7(1):2722.
Score: 0.045
-
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection. 2017 Apr; 45(2):209-213.
Score: 0.044